인슐린 유사 성장인자 시장 : 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Insulin-like growth factors market size was valued at USD 277.90 Million in 2023, expanding at a CAGR of 5.33% from 2024 to 2032.

Insulin-like growth factors (IGFs) are naturally occurring proteins with structural similarity to insulin, playing a crucial role in growth and development. Primarily produced in the liver, IGFs are essential for cellular growth, tissue development, and overall metabolism regulation. The two main types, IGF-1 and IGF-2, function by binding to specific receptors on cell surfaces, activating pathways that promote cell division, protein synthesis, and muscle growth. IGF-1 is crucial for postnatal growth and is involved in tissue repair and regeneration.

Insulin-like Growth Factors Market- Market Dynamics

Increasing demand for regenerative medicine to propel market growth

The regenerative medicine sector is expanding, with a projected growth rate of 20% annually. This is expected to boost the demand for IGF-1 due to its role in tissue repair and muscle regeneration. Besides, the growing prevalence of diabetes, age-related disorders, and the rising focus on pediatric endocrinology are other factors projected to boost the growth of the insulin-like growth factors market. However, treatments involving IGF-1 therapies can be costly, limiting accessibility and adoption, especially in low- to middle-income countries. Moreover, the advancements in genetic engineering and the ongoing research & development efforts focused on understanding the mechanisms of IGFs are projected to provide massive growth opportunities for the market. Furthermore, governments and private entities are boosting funding for rare disease research, which is boosting industry growth.

Insulin-like Growth Factors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.33% over the forecast period (2024-2032)

Based on type segmentation, mechano growth factor is predicted to grow at the fastest rate during the forecast period.

Based on end-user segmentation, hospitals was the leading segment in 2023

On the basis of region, the North America insulin-like growth factors market was the leading revenue generator in 2023

Insulin-like Growth Factors Market- Segmentation Analysis:

The Global Insulin-like Growth Factors Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into three categories based on type: somatomedin C, mechano growth factor, and IGF 1. The mechano growth factor sector is estimated to dominate the market. This is primarily due to its ability to promote muscle protein production. Its strong mitogenic effect supports cell proliferation, aiding tissue regeneration, wound healing, and the development of muscles and organs.

The market is divided into five categories based on application: breast cancer, alzheimer's disease, muscular dystrophy, huntington disease, and others. The muscular dystrophy sector dominates the market and is likely to maintain its dominance during the forecast period. This growth is driven by the increasing need for effective treatments to counter muscle degeneration and the rising focus on regenerative medicine.

Insulin-like Growth Factors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Insulin-like Growth Factors Market- Competitive Landscape:

A key driver in the insulin-like growth factor market is the increased demand for regenerative and therapeutic applications. Competitors prioritize strategies like expanding geographical reach and refining product portfolios to strengthen their market presence. Emphasis is placed on research and development for innovative products, allowing companies to meet evolving healthcare demands. Strategic partnerships, mergers, and acquisitions are also common, helping companies diversify and secure their competitive standing. Additionally, top players leverage regional expansion and customized solutions to enhance customer engagement, establishing themselves as leaders while mitigating competitive threats. This multi-faceted approach aligns with the industry's growth trajectory and customer needs.

Recent Developments:

In October 2024, Eton Pharmaceuticals entered into an agreement to acquire Increlex(R) (mecasermin injection) from Ipsen S.A., with the deal anticipated to close by year-end 2024. Increlex(R) is vital for treating severe IGF-1 deficiency, an ultra-rare condition, aligning with Eton's commitment to rare disease treatment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Boehringer Ingelheim International GmbH
• Genervon Biopharmaceuticals LLC
• Ascendis Pharma
• Regulaxis SAS
• MedImmune, LLC
• Helixmith Co Ltd.
• SIFI SpA
• Stem Cell Medicine Ltd.
• Others

GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Somatomedin C
• Mechano Growth Factor
• IGF 1

GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Breast Cancer
• Alzheimer's Disease
• Muscular Dystrophy
• Huntington Disease
• Others

GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Medical Centers
• Hospitals

GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Insulin-like Growth Factors Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Insulin-like Growth Factors Market Snippet by Type
  • 2.1.2. Insulin-like Growth Factors Market Snippet by Application
  • 2.1.3. Insulin-like Growth Factors Market Snippet by End User
  • 2.1.4. Insulin-like Growth Factors Market Snippet by Country
  • 2.1.5. Insulin-like Growth Factors Market Snippet by Region
• 2.2. Competitive Insights

3. Insulin-like Growth Factors Key Market Trends

• 3.1. Insulin-like Growth Factors Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Insulin-like Growth Factors Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Insulin-like Growth Factors Market Opportunities
• 3.4. Insulin-like Growth Factors Market Future Trends

4. Insulin-like Growth Factors Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Insulin-like Growth Factors Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Insulin-like Growth Factors Market Landscape

• 6.1. Insulin-like Growth Factors Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Insulin-like Growth Factors Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 7.1.2. Somatomedin C
  • 7.1.3. Mechano Growth Factor
  • 7.1.4. IGF 1

8. Insulin-like Growth Factors Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Breast Cancer
  • 8.1.3. Alzheimer's Disease
  • 8.1.4. Muscular Dystrophy
  • 8.1.5. Huntington Disease
  • 8.1.6. Others

9. Insulin-like Growth Factors Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 9.1.2. Medical Centers
  • 9.1.3. Hospitals

10. Insulin-like Growth Factors Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Insulin-like Growth Factors Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Insulin-like Growth Factors Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Insulin-like Growth Factors Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Insulin-like Growth Factors Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Insulin-like Growth Factors Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Insulin-like Growth Factors Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Boehringer Ingelheim International GmbH
  • 11.2.2. Genervon Biopharmaceuticals LLC
  • 11.2.3. Ascendis Pharma
  • 11.2.4. Regulaxis SAS
  • 11.2.5. MedImmune, LLC
  • 11.2.6. Helixmith Co Ltd.
  • 11.2.7. SIFI SpA
  • 11.2.8. Stem Cell Medicine Ltd.
  • 11.2.9. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us